One Inc Launches Pre-Built Payment Integration for Verisk's FAST Life Insurance Platform
FOLSOM, Calif.--(BUSINESS WIRE)-- One Inc, the leading digital payments network for the insurance industry, today announced the launch of a pre-built payment integration for Verisk's FAST ('Flexible Architecture, Simplified Technology'), a modern, flexible platform designed to streamline and scale life insurance operations. This new integration connects One Inc's industry-leading PremiumPay® for inbound payment capabilities directly into FAST's configurable system architecture, helping carriers accelerate their digital transformation by reducing the need for physical and non-direct payments in the life and annuity market.
Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, and its FAST platform enable life insurers to quickly modernize and mitigate challenges spanning the life insurance life cycle, such as product development, customer self-service, policy administration and claims management. The company's integrated solutions accelerate carriers' time to market and deliver a superior digital policyholder experience. Integrating One Inc's payment technology within Verisk's FAST platform enables carriers to:
Offer a modern payment experience and enhance communication with policyholders via one convenient platform.
Simplify digitalization and automate critical processes to drive greater efficiency and scalability across life and annuity lines.
Mitigate outdated strategies and operational costs associated with digitalization.
'At Verisk, we are committed to helping life insurers by providing data-rich solutions to achieve greater speed, flexibility and operational efficiency,' said Saurabh Khemka, co-president of underwriting solutions at Verisk. 'By integrating digital payment capabilities in collaboration with PremiumPay, carriers can accelerate their modernization efforts, reduce complexity and deliver improved customer experiences without the time and cost associated with updating their existing platforms.'
'This product integration offers a critical path to unlocking value from digital payments tailored to the needs of life insurers,' said Ian Drysdale, CEO of One Inc. 'We can eliminate the typical barriers of custom integrations and enable carriers to adopt modern inbound payment capabilities with greater speed and efficiency. This collaboration emphasizes our strengths to modernize the life insurance landscape while offering a unified platform for payments.'
About One Inc
One Inc is modernizing the insurance industry for over 270 carriers through a unified and frictionless payment network. Specializing solely in insurance, One Inc enhances carrier operations by cutting costs, boosting security, and improving customer experience. Their all-inclusive digital payments platform offers diverse payment options, multi-channel communications, and swift claim settlements, even for complex cases. As a leading digital payments platform, One Inc handles billions in premiums and claims annually. Recently acknowledged by CNBC as one of the World's Top Fintech Companies and consistently listed on the Inc. 5000 list of Fastest-Growing Companies over the past three years, One Inc stands as a leader in fintech innovation. For more details, please visit www.oneinc.com.
About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong. For more, visit Verisk.com and the Verisk Newsroom.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
13 minutes ago
- Business Wire
Cheniere Partners Announces Pricing of $1.0 Billion Senior Notes due 2035
HOUSTON--(BUSINESS WIRE)--Cheniere Energy Partners, L.P. ('Cheniere Partners') (NYSE: CQP) announced today that it has priced its previously announced offering of Senior Notes due 2035 (the 'CQP 2035 Notes'). The CQP 2035 Notes will bear interest at a rate of 5.550% per annum and will mature on October 30, 2035. The CQP 2035 Notes will be issued at a price equal to 99.731% of par. The closing of the offering is expected to occur on July 10, 2025. Cheniere Partners intends to contribute the proceeds from the offering to its subsidiary, Sabine Pass Liquefaction, LLC, to be used to redeem a portion of the outstanding aggregate principal amount of its senior secured notes due 2026 (the 'SPL 2026 Notes'). This press release does not constitute an offer to purchase or a solicitation of an offer to sell the SPL 2026 Notes or a notice of redemption under the indenture governing the SPL 2026 Notes. The CQP 2035 Notes will rank pari passu in right of payment with the existing senior notes at Cheniere Partners, including the senior notes due 2029, the senior notes due 2031, the senior notes due 2032, the senior notes due 2033 and the senior notes due 2034. The offer of the CQP 2035 Notes has not been registered under the Securities Act of 1933, as amended (the 'Securities Act'), and the CQP 2035 Notes may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from the registration requirements of the Securities Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale of these securities would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Forward-Looking Statements This press release contains certain statements that may include 'forward-looking statements.' All statements, other than statements of historical or present facts or conditions, included herein are 'forward-looking statements.' Included among 'forward-looking statements' are, among other things, (i) statements regarding Cheniere Partners' financial and operational guidance, business strategy, plans and objectives, including the development, construction and operation of liquefaction facilities, (ii) statements regarding Cheniere Partners' anticipated quarterly distributions and ability to make quarterly distributions at the base amount or any amount, (iii) statements regarding regulatory authorization and approval expectations, (iv) statements expressing beliefs and expectations regarding the development of Cheniere Partners' LNG terminal and liquefaction business, (v) statements regarding the business operations and prospects of third-parties, (vi) statements regarding potential financing arrangements, (vii) statements regarding future discussions and entry into contracts, and (viii) statements relating to our goals, commitments and strategies in relation to environmental matters. Although Cheniere Partners believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Cheniere Partners' actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Cheniere Partners' periodic reports that are filed with and available from the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, Cheniere Partners does not assume a duty to update these forward-looking statements.
Yahoo
14 minutes ago
- Yahoo
How major US stock indexes fared Wednesday, 6/25/2025
U.S. stocks hung near their all-time high as financial markets caught a breath following two big days bolstered by hopes that the Israel-Iran war will not disrupt the global flow of crude oil. The S&P 500 barely budged on Wednesday and is sitting just 0.8% below its all-time high. The Dow Jones Industrial Average dipped 0.2%, and the Nasdaq composite rose 0.3%. Oil prices stabilized after plunging by roughly $10 per barrel in the prior two days. Stock indexes fell modestly in Europe after rising in Asia, and Treasury yields held relatively steady in the bond market. On Wednesday: The S&P 500 fell 0.02 points, or less than 0.1%, to 6,092.16. The Dow Jones Industrial Average fell 106.59 points, or 0.2%, to 42,982.43. The Nasdaq composite rose 61.02 points, or 0.3%, to 19,973.55. The Russell 2000 index of smaller companies fell 25.03 points, or 1.2%, to 2,136.18. For the week: The S&P 500 is up 124.32 points, or 2.1%. The Dow is up 775.61 points, or 1.8%. The Nasdaq is up 526.14 points, or 2.7%. The Russell 2000 is up 26.92 points, or 1.3%. For the year: The S&P 500 is up 210.53 points, or 3.6%. The Dow is up 438.21 points, or 1%. The Nasdaq is up 662.76 points, or 3.4%. The Russell 2000 is down 93.97 points, or 4.2%.
Yahoo
14 minutes ago
- Yahoo
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ('Reviva' or the 'Company'), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it intends to offer shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in a public offering. All of the securities to be sold in the offering are to be offered by Reviva. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering. The Company currently intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes. The securities will be offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-276848), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the 'SEC') on February 2, 2024, and declared effective by the SEC on February 13, 2024. A preliminary prospectus supplement will be filed with the SEC and will be available on the SEC's website at Copies of the preliminary prospectus supplement and accompanying base prospectus, when available, may be obtained from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@ This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Reviva Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva's current pipeline focuses on the central nervous system (CNS), inflammatory and cardiometabolic diseases. Reviva's pipeline currently includes two drug candidates, brilaroxazine (RP5063) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both brilaroxazine and RP1208 in the United States, Europe, and several other countries. Forward-Looking Statements This release contains 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as 'believes,' 'expects,' 'anticipates,' 'intends,' 'will,' 'may,' 'should,' or similar expressions. These forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering and uncertainties related to the size, timing, completion, and use of proceeds from the proposed offering. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the Company's business in general, please refer to the Company's prospectus supplement to be filed with the SEC, and the documents incorporated by reference therein, including the Company's Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. We have no obligation, and expressly disclaim any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise. REVIVA CONTACTS: Corporate Contact:Reviva Pharmaceuticals Holdings, Bhat, Investor Relations Contact:LifeSci Advisors, LLCPJ Kelleherpkelleher@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
